Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Change in Taxes (2024 - 2025)

Agios Pharmaceuticals (AGIO) has disclosed Change in Taxes for 5 consecutive years, with -$683000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Change in Taxes changed N/A year-over-year to -$683000.0, compared with a TTM value of -$871000.0 through Dec 2025, down 200.0%, and an annual FY2025 reading of -$871000.0, down 200.0% over the prior year.
  • Change in Taxes was -$683000.0 for Q2 2025 at Agios Pharmaceuticals, down from -$188000.0 in the prior quarter.
  • Across five years, Change in Taxes topped out at $52.7 million in Q3 2024 and bottomed at -$51.8 million in Q4 2024.